Induction Quadruplet Therapy and Minimal/Measurable Residual Disease (MRD)-Informed Treatment Adaptation in Newly Diagnosed Multiple Myeloma (NDMM): Results from an Academic-Community Pathway
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:8048-8049 - Subject
- Language
- ISSN
- 0006-4971